Searched for
CLARI5
A quiet Gulf player may steal Pakistan’s ‘miracle’ momentNegotiations around a possible Iran–US ceasefire have shifted focus towards a Gulf state near the Strait of Hormuz, raising questions over ...- B2B SaaS company Perfios acquires debt management firm CreditNirvanaPerfios has acquired debt management platform CreditNirvana, its second acquisition in a month. The deal strengthens its end-to-end financi...
- Perfios acquires fraud detection platform Clari5Perfios acquired fraud detection platform Clari5 to enhance its fraud management capabilities. Clari5, with 200 employees, becomes a Perfio...
- Claris Life hits record high but pares most gains over regulatory concernsAnalyst who ET spoke to said the management expressed confidence that an escalation would not happen.
- Baxter to acquire Claris Injectables for Rs 4,237 crore"The Boards of Directors of both companies have approved the proposed acquisition, which is expected to close in the second half of 2017," ...
- Top PE firms join race for Claris Lifesciences’ US businessThe business is expected to be valued at over $500 million and may also attract interest from a Chinese drugmaker and some Indian pharma co...
- Claris Lifesciences gets USFDA nod for Flumazenil injectionThe company has received abbreviated new drug approval from the United States Food and Drug Administration (USFDA) for Flumazenil injection.
- Claris Life gets USFDA nod for generic anesthetic injectionThe injection is indicated for the production of local or regional anesthesia or analgesia for surgery, diagnostic and therapeutic procedur...
- Claris Lifesciences gets nod to resume supply of Furosemide injection in USClaris Lifesciences said it has received prior approval supplement (PAS) for Furosemide injection which will help it to resume supply in th...
- Carlyle Group sells its entire 11.29% stake in Claris LifesciencesCarlyle Group offloaded its entire 11.29 per cent stake in drug-maker Claris Lifesciences for a little over Rs 170 crore through an open ma...
- Claris Lifesciences shares up 3.5 per cent on BSEStock of Claris Life ended the day 3.56 per cent higher at Rs 181.60 on the BSE. In intra-day, it gained 6.33 per cent to Rs 186.45.
- Claris Lifesciences rallies over 8% on share buyback plan"The objective of the buy-back is to return surplus cash to the equity shareholders of the company," Claris said in a filing to the BSE.
- Claris to buy-back 14.49 per cent stake for Rs 231.25 crore"The objective of the buy-back is to return surplus cash to the equity shareholders of the company," Claris said in a filing to the BSE.
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Claris promoter sells 12 lakh shares for over Rs 23 croreClaris Lifesciences promoter Aditya Sushil Kumar Handa today offloaded nearly 12 lakh shares of the pharma company for over Rs 23 crore.
- Claris Lifesciences Net Profit dips 27%, revenue down by 5%Claris Lifesciences Ltd, net profit dips successive for second time in a year. The net profit for the third quarter dropped by 27.34% and r...
- Adani group, Claris Lifesciences stock prices fall sharplyStock prices of Adani group companies and Claris Lifesciences fell sharply on Monday when the benchmark BSE Sensex closed 104 points lower.
- Claris Lifesciences promoter sells 10 lakh sharesAditya Sushil Kumar Handa, one of the promoters of Claris Lifesciences, today sold 10 lakh shares of the drug company.
- Claris Lifesciences yet to get USFDA clearanceClaris Lifesciences said its consolidated net profit rose 9% for the first quarter of calendar year 2012 to Rs 21.7 crore.
- Citi offloads over 3 lakh shares of Claris LifesciencesForeign fund house Citigroup sold 3.19 lakh shares, worth about Rs 5 crore, of drug-maker Claris Lifesciences through an open market transa...
Load More- Claris Life hits record high but pares most gains over regulatory concerns
